Back to search

Article

The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy

2025-04-05

Abstract excerpt

<h4>ABSTRACT</h4> Radioimmunotherapy (RIT) is used to treat patients with hematological malignancies known to infiltrate the bone marrow (BM) microenvironment. RIT uses target-specific monoclonal antibodies stably conjugated to radionuclides to deliver cytotoxic radiation to cells of interest. While RIT is effective at delivering radiation to cancer cells, normal tissue is also exposed to radiation upon RIT, the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1245a9cd-19c5-5e5a-8617-e16baaf46a32
DOI
10.1101/2025.04.04.645037
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapyDOI 10.1101/2025.04.04.645037
Select a neighboring publication to make it the new centre.